Patent · US Active

Solid state forms of a potent HCV inhibitor

US8598183B2 · kind B2 · utility

0Cited by

7References

29Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Rolf-Stefan Brickl
Shirlynn Chen · Somers, US
Jihchin CHUNG · Princeton Junction, US
Mayur Suryakant DUDHEDIA · Brookfield, US
Danping Li · Middlebury, US
Zhi-Hui Lu · Glen Allen, US
Siddharthya Mujumdar · Basel, CH
Chitra TELANG · Brookfield, US
Richard J. Varsolona · Scotch Plains, US
Zeren Wang · Longchuan, CN

Key dates

Filing date	Sep 23, 2011
Grant date	Dec 3, 2013
Priority date	—
Expiry date	Jun 1, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel sodium salt forms of the following Compound (1), and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.